Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 276 clinical trials
Virtual Reality Behavioral Activation: An Intervention for Major Depressive Disorder

The primary purpose of this study is to test the safety and feasibility of virtual reality (VR) technology in the use of behavioral activation (BA) as a treatment for major depressive disorder (MDD). The secondary purpose of this study is to examine whether any evidence of clinical efficacy exists for …

major depressive disorder
depressive disorder
  • 0 views
  • 16 Feb, 2024
  • 1 location
Safety of Liposom With Citalopram in Elderly Patients With Major Depressive Disorder

The purpose of this study is to determine if Liposom Forte will enhance the response to antidepressant therapy with citalopram in elderly patients suffering from Major Depressive Disorder (MDD).

  • 0 views
  • 11 Oct, 2021
  • 16 locations
testslug trial title

Major depressive disorder (MDD) is a common, recurrent, and frequent chronic disorder. Treatment is often challenging; up to 40% of patients do not benefit sufficiently from existing antidepressant interventions including trials of medication and psychotherapy.

  • 0 views
  • 09 Jul, 2021
Improving Outcomes in Adolescent Inpatient Depression With Deep Transcranial Magnetic Stimulation (IMPACT-D)  

Evaluate the feasibility, safety, and preliminary efficacy of deep Transcranial Magnetic Stimulation (dTMS) as an adjunctive treatment for adolescents hospitalized with major depressive disorder (MDD).

  • 0 views
  • 17 Oct, 2025
Effectiveness of Walking Exercise in Improving Depression in Older Adults With Major Depressive Disorder A Pilot Study

This pilot randomized controlled trial aims at investigating the effects of different intensities of aerobic walking exercise to alleviate depression in older adults with major depressive disorder. Both baseline and post-intervention measurements will be conducted at the Exercise Physiology Laboratory, Division of Kinesiology, School of Public Health, The University of …

  • 0 views
  • 05 Aug, 2020
Ketamine or Placebo in Patients With Major Depression and Advanced Cancer

Major depression (MD) is a psychiatric disorder characterized by a persistent feeling of sadness, anhedonia or a decreased perception of pleasurable experiences, as well as appetite alterations and weight variations, sleep disorders, altered psychomotor skills, fatigue, guilt, decreased self-worth, suicidal thoughts and difficulty concentrating in a task (1).

cancer diagnosis
sleep disorder
fatigue
anhedonia
advanced cancer
  • 0 views
  • 16 Feb, 2024
  • 1 location
RCT for Electroconvulsive Treatment Followed by Cognitive Control Training

Major depressive disorder (MDD) is worldwide one of the most prevalent and disabling mental health conditions. Electroconvulsive therapy (ECT) is a safe and effective treatment even though 6-month relapse rates are high.

  • 0 views
  • 05 Aug, 2020
Mechanism of Action of Transcranial Magnetic Stimulation

This is an observational neuroimaging study assessing the effects of TMS on the brains of patients with unipolar depression.

psychiatric treatment
psychiatric care
major depressive disorder
depressive episode
transcranial magnetic stimulation
  • 0 views
  • 16 Feb, 2024
  • 1 location
Accelerated iTBS for Depressed Patients During the COVID-19 Pandemic

The current study aims to assess the feasibility, acceptance and clinical outcomes of a practical high-dose aiTBS protocol, including tapering treatments and symptom-based relapse prevention treatments, in patients with unipolar depression previously responsive to ECT and patients needing urgent treatment due to symptom severity during the COVID-19 pandemic.

depression
depressed mood
depressive episode
major depressive disorder
psychotic symptoms
  • 0 views
  • 16 Feb, 2024
  • 1 location
High Dose Accelerated iTBS for Depression

This trial will compare active intermittent theta burst stimulation (iTBS) rTMS in an accelerated treatment schedule (8 treatment sessions per day for 5 days) to a placebo control. Depression symptom severity will be measured before, during, at end of treatment, 1-week post and 4-weeks post treatment.

depressive symptoms
antidepressants
depression
treatment regimen
transcranial magnetic stimulation
  • 0 views
  • 16 Feb, 2024
  • 3 locations